440 related articles for article (PubMed ID: 32605658)
41. Nrf2 Knockdown Disrupts the Protective Effect of Curcumin on Alcohol-Induced Hepatocyte Necroptosis.
Lu C; Xu W; Zhang F; Shao J; Zheng S
Mol Pharm; 2016 Dec; 13(12):4043-4053. PubMed ID: 27764939
[TBL] [Abstract][Full Text] [Related]
42. Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene.
Montel AM; Dos Santos RG; da Costa PR; Silveira-Lacerda EP; Batista AA; Dos Santos WG
Biometals; 2017 Apr; 30(2):295-305. PubMed ID: 28258507
[TBL] [Abstract][Full Text] [Related]
43. Interplay between Endoplasmic Reticulum (ER) Stress and Autophagy Induces Mutant p53H273 Degradation.
Garufi A; Federici G; Gilardini Montani MS; Crispini A; Cirone M; D'Orazi G
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32138264
[TBL] [Abstract][Full Text] [Related]
44. Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?
Catanzaro E; Calcabrini C; Turrini E; Sestili P; Fimognari C
Expert Opin Ther Targets; 2017 Aug; 21(8):781-793. PubMed ID: 28675319
[TBL] [Abstract][Full Text] [Related]
45. SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.
Kolukula VK; Sahu G; Wellstein A; Rodriguez OC; Preet A; Iacobazzi V; D'Orazi G; Albanese C; Palmieri F; Avantaggiati ML
Oncotarget; 2014 Mar; 5(5):1212-25. PubMed ID: 24681808
[TBL] [Abstract][Full Text] [Related]
46. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
47. The Expression of TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Can Be Controlled by the Antioxidant Orchestrator NRF2 in Human Carcinoma Cells.
Simon-Molas H; Sánchez-de-Diego C; Navarro-Sabaté À; Castaño E; Ventura F; Bartrons R; Manzano A
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163828
[TBL] [Abstract][Full Text] [Related]
48. Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
Baghi N; Bakhshinejad B; Keshavarz R; Babashah S; Sadeghizadeh M
Gene; 2018 Sep; 670():55-62. PubMed ID: 29753810
[TBL] [Abstract][Full Text] [Related]
49. Nrf2 is a key factor in the reversal effect of curcumin on multidrug resistance in the HCT‑8/5‑Fu human colorectal cancer cell line.
Zhang C; He LJ; Ye HZ; Liu DF; Zhu YB; Miao DD; Zhang SP; Chen YY; Jia YW; Shen J; Liu XP
Mol Med Rep; 2018 Dec; 18(6):5409-5416. PubMed ID: 30365132
[TBL] [Abstract][Full Text] [Related]
50. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy.
Zhu J; Wang H; Chen F; Fu J; Xu Y; Hou Y; Kou HH; Zhai C; Nelson MB; Zhang Q; Andersen ME; Pi J
Free Radic Biol Med; 2016 Oct; 99():544-556. PubMed ID: 27634172
[TBL] [Abstract][Full Text] [Related]
51. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells.
Watson JL; Hill R; Yaffe PB; Greenshields A; Walsh M; Lee PW; Giacomantonio CA; Hoskin DW
Cancer Lett; 2010 Nov; 297(1):1-8. PubMed ID: 20472336
[TBL] [Abstract][Full Text] [Related]
52. Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications.
Baldari S; Ubertini V; Garufi A; D'Orazi G; Bossi G
Cell Death Dis; 2015 Jan; 6(1):e1621. PubMed ID: 25633290
[TBL] [Abstract][Full Text] [Related]
53. Alkylating Agent-Induced NRF2 Blocks Endoplasmic Reticulum Stress-Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis.
Zanotto-Filho A; Masamsetti VP; Loranc E; Tonapi SS; Gorthi A; Bernard X; Gonçalves RM; Moreira JC; Chen Y; Bishop AJ
Mol Cancer Ther; 2016 Dec; 15(12):3000-3014. PubMed ID: 27638861
[TBL] [Abstract][Full Text] [Related]
54. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.
Bush JA; Cheung KJ; Li G
Exp Cell Res; 2001 Dec; 271(2):305-14. PubMed ID: 11716543
[TBL] [Abstract][Full Text] [Related]
55. Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation.
Kong LR; Ong RW; Tan TZ; Mohamed Salleh NAB; Thangavelu M; Chan JV; Koh LYJ; Periyasamy G; Lau JA; Le TBU; Wang L; Lee M; Kannan S; Verma CS; Lim CM; Chng WJ; Lane DP; Venkitaraman A; Hung HT; Cheok CF; Goh BC
Nat Commun; 2020 Apr; 11(1):2086. PubMed ID: 32350249
[TBL] [Abstract][Full Text] [Related]
56. Anticancer effect of AZD2461 PARP inhibitor against colon cancer cells carrying wt or dysfunctional p53.
Romeo MA; Gilardini Montani MS; Benedetti R; Arena A; Maretto M; Bassetti E; Caiazzo R; D'Orazi G; Cirone M
Exp Cell Res; 2021 Nov; 408(2):112879. PubMed ID: 34653407
[TBL] [Abstract][Full Text] [Related]
57. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.
Banerjee S; Chakravarty AR
Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541
[TBL] [Abstract][Full Text] [Related]
58. Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells.
Ghaleb A; Padellan M; Marchenko N
Breast Cancer Res; 2020 Dec; 22(1):133. PubMed ID: 33267874
[TBL] [Abstract][Full Text] [Related]
59. BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer.
Liu JZ; Hu YL; Feng Y; Jiang Y; Guo YB; Liu YF; Chen X; Yang JL; Chen YY; Mao QS; Xue WJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):123. PubMed ID: 32605589
[TBL] [Abstract][Full Text] [Related]
60. Curcumin attenuates quinocetone induced apoptosis and inflammation via the opposite modulation of Nrf2/HO-1 and NF-kB pathway in human hepatocyte L02 cells.
Dai C; Li B; Zhou Y; Li D; Zhang S; Li H; Xiao X; Tang S
Food Chem Toxicol; 2016 Sep; 95():52-63. PubMed ID: 27375190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
